Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.38 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.34 |
| ▸ | PRKDC | P78527 | 5/20 | 0.33 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.33 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.33 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.33 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.33 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | KRAS | P01116 | 1/20 | 0.32 |
| ▸ | NOS1 | P29475 | 1/20 | 0.31 |
| ▸ | GPR3 | P46089 | 1/20 | 0.31 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20062631 | 0.90 | ALOX5 (0.38) | ALOX5PARP14HTTPAX8PRKDC | |
| SCHEMBL20062472 | 0.82 | ALOX5 (0.41) | ALOX5PARP14HTTPAX8PRKDC | |
| SCHEMBL24596660 | 0.80 | ALOX5 (0.43) | ALOX5PARP14PRKDCPIK3CDPIK3CB | |
| SCHEMBL20062587 | 0.80 | PARP14 (0.40) | ALOX5PARP14HTTPAX8PRKDC | |
| SCHEMBL20062592 | 0.80 | PARP14 (0.40) | ALOX5PARP14HTTPAX8PRKDC | |
| SCHEMBL20062593 | 0.80 | PARP14 (0.40) | ALOX5PARP14HTTPAX8PRKDC | |
| SCHEMBL14925822 | 0.79 | ALOX5 (0.43) | ALOX5PARP14HTTPAX8PRKDC | |
| SCHEMBL20062589 | 0.79 | PARP14 (0.39) | ALOX5PARP14HTTPAX8PRKDC | |
| SCHEMBL20062585 | 0.79 | PARP14 (0.39) | ALOX5PARP14HTTPAX8PRKDC | |
| SCHEMBL14826852 | 0.79 | PARP14 (0.39) | ALOX5PARP14HTTPAX8PRKDC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10608185-B2 | Organic electroluminescent materials and devices | UNIVERAL DISPLAY CORPORATION (US) | 2020-03-31 | — | — | US | disclosed |
| US-20180108844-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2018-04-19 | — | — | US | disclosed |
| US-20180108844-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2018-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180108844-A1 | Organic Electroluminescent Materials and Devices | SLCO4C1, SLCO2A1, SLCO2B1 | ALOX5 1559/4885PARP14 2592/4885HTT 1056/4885 |
| US-10608185-B2 | Organic electroluminescent materials and devices | SLCO4C1, SLCO2A1, SLCO2B1 | ALOX5 1559/4885PARP14 2592/4885HTT 1056/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.